COVID-19 antiviral drugs worth over £550 million wasted in the UK
Britain has the highest unused stock of Paxlovid in Europe, with an estimated 1 million expired courses
More than 1.5 million courses of Pfizer’s COVID-19...
PDA issues advisory on ‘Paxlovid’ antiviral treatment for non-hospitalised patients
The Pharmacists’ Defence Association (PDA) has issued an advisory information to community pharmacy contractors about Paxlovid antiviral treatment for non-hospitalised patients.
“Patients will be assessed...
MHRA approves second oral Covid-19 antiviral, Paxlovid
UK regulator has approved a second oral antiviral for early treatment of Covid-19 in high-risk adults, after molnupiravir called Paxlovid.
The Medicines and Healthcare products Regulatory...